SARAH BANNISTER: Open Payments
NPI 1700178258 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,207 in 114 payments from 17 companies in 2025. Trend: 2023 $2,086 · 2024 $2,119 · 2025 $2,207
Food & beverage: $2,207
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 17 | $385 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $278 |
| Teva Pharmaceuticals USA, Inc. | 12 | $205 |
| Alkermes, Inc. | 11 | $186 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $165 |
| Axsome Therapeutics, Inc. | 7 | $155 |
| Otsuka America Pharmaceutical, Inc. | 7 | $151 |
| Corium, LLC | 5 | $142 |
| Janssen Pharmaceuticals, Inc | 5 | $136 |
| ABBVIE INC. | 5 | $103 |
Products named: INGREZZA, CAPLYTA, REXULTI, AUSTEDO XR, TRINTELLIX, Azstarys, SPRAVATO, Auvelity.
Industry payments across TN — which companies pay providers there.
